May 12, 2022
ENA Respiratory Selected for BLUE KNIGHT™ to Accelerate Development of Pan-Antiviral Nasal Spray
Read moreENA Respiratory Selected for BLUE KNIGHT™ to Accelerate Development of Pan-Antiviral Nasal Spray
Read moreAustralian collaboration and AU$10m investment fuels Ankere Therapeutics’ efforts to target inflammatory lung conditions
Read morePolyActiva Announces Positive Phase IIa Trial Results in Low Dose Cohort for PA5108 Ocular Implant with Prezia™ Sustained Drug Delivery Technology
Read moreGlyscend Therapeutics Announces Initiation of Phase 1 Clinical Trial on the Heels of Preclinical Data Presented at EASD 2021 on the Metabolic Benefits of its Oral Polymer-based Duodenal Exclusion Therapy
Read moreAllay Therapeutics Completes Oversubscribed $60M Financing to Advance Ultra-Sustained Pain Platform
Read more$14m invested in world-leading RNA therapy: University of Otago spinout targeting new cancer treatments
Read moreIndustry-led leadership programme launched to support women into more top science and innovation roles
Read moreOncoRes Medical receives $150,000 funding boost from Western Australian Government
Read moreMyricx Pharma Launches with £4.5M (AU$8.2M) Financing to Progress its Novel NMT inhibitors in Cancer
Read moreAzura Ophthalmics raises AUD$28m for registration studies for treatment of leading cause of dry eye disease
Read moreVaxxas Announces US$22 Million (A$30.6 Million) Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response
Read moreVaxxas announces that MSD Exercises Option to Apply Novel Immune System Activation Platform for Vaccine Candidate
Read moreQUE Oncology recruiting Sydney breast cancer patients experiencing hot flushes & night sweats
Read more$14m invested in University of Melbourne spin-out to create vaccine for periodontal gum disease
Read morePerth tech joint-winner in global finals for international start-up competition
Read moreLevel 9, 31 Queen Street
Melbourne VIC 3000
Phone +61 3 9657 0700
Email: info@brandonbiocatalyst.com
Suite 2.05, 1 York Street
Sydney NSW 2000
Phone +61 2 8227 7080
Email: info@brandonbiocatalyst.com
Damon Birrell
Caleb Hulme-Moir